iCAD received FDA OK on iQ CAD system

The FDA has cleared iCAD Inc.'s new iCAD iQ computer-aided detection (CAD) system for marketing.

 The iQ system is designed specifically for women's health centers and breast clinics that perform less than 20 mammography procedures per day. Shipments of iQ are set for the fourth quarter.

 The FDA approval also permits use of iCAD's new Fulcrum digitizer in connection with its MammoReader CAD products. The company said the OK will permit iCAD to expand its product offerings in the area of networked CAD, in which satellite mammography screening and film scanning points are networked and connected in a so-called hub and spoke configuration using the iCAD MammoReader's central CAD database.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup